CA 2024 * | 60,47 Md 54,66 Md | CA 2025 * | 62,71 Md 56,69 Md | Capitalisation | 158 Md 143 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 7,28 Md 6,58 Md | Résultat net 2025 * | 10,81 Md 9,77 Md | VE / CA 2024 * | 3,59 x |
Dette nette 2024 * | 59,14 Md 53,46 Md | Dette nette 2025 * | 54,22 Md 49,02 Md | VE / CA 2025 * | 3,38 x |
PER 2024 * |
20,5
x | PER 2025 * |
14
x | Employés | - |
Rendement 2024 * |
6% | Rendement 2025 * |
6,12% | Flottant | 59,05% |
Dernier transcript sur Pfizer Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 01/01/93 |
David Denton
DFI | Director of Finance/CFO | 59 | 02/05/22 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 66 | 01/04/20 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 23/02/17 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 27/09/13 |
Nom | PEA | Position | Varia. 1 janv. | Notation |
---|---|---|---|---|
STRATÉGIE SANTÉ | Non | 2.34M EUR | -3,00% | |
SG ACTIONS MONDE SÉLECTION C | Non | 5M EUR | +12,00% | |
AMUNDI FDS PIO GLOBAL EQUITY A EUR C | Non | 59.29M EUR | +12,00% | |
AXAWF II NORTH AMERICAN EQS A DIS USD | Non | 4.74M USD | +15,00% | |
LIONTRUST GF TORTOISE R EURH | Non | 8.58M EUR | +7,00% |
Varia. 1 janv. | Capi. | |
---|---|---|
+55,55% | 823 Md | |
+42,31% | 641 Md | |
-6,83% | 352 Md | |
+17,15% | 324 Md | |
+7,09% | 301 Md | |
+14,02% | 241 Md | |
+1,64% | 223 Md | |
+13,66% | 218 Md | |
+7,87% | 167 Md |